Search results for "Cardiology"
Fondaparinux associated with better outcomes than LMWH in NSTEMI study
Fondaparinux was associated with lower risk of major bleeding and death than low-molecular-weight heparin (LMWH) for patients with non-ST-segment elevation myocardial infarction (NSTEMI), a recent prospective study found.
https://immattersacp.org/weekly/archives/2015/02/24/6.htm
24 Feb 2015
Intensive blood pressure control in older patients associated with decreased cardiovascular events
Intensive blood pressure control led to a decreased rate of major adverse cardiovascular events, including cardiovascular death and heart failure, in older adults with hypertension, the study concluded.
https://immattersacp.org/weekly/archives/2017/01/31/1.htm
31 Jan 2017
Target preop visits for efficiency, best outcomes
Internists can guide preoperative anticoagulation, ensure that patients are in optimal condition for procedures, and##mdash;perhaps most importantly##mdash;judiciously choose which tests to perform and which ones aren't needed.
https://immattersacp.org/archives/2014/09/preop.htm
1 Sep 2014
Warfarin associated with lower stroke, systemic thromboembolism risk in patients with both afib and CKD
The addition of chronic kidney disease (CKD) to atrial fibrillation is associated with an increased risk of stroke or systemic thromboembolism and bleeding. Warfarin treatment was associated with decreasing this risk, a new study found.
https://immattersacp.org/weekly/archives/2012/08/21/6.htm
21 Aug 2012
ARBs may offer same efficacy, better tolerability than ACE inhibitors
Meta-regression analysis showed that the difference between angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) compared with placebo was due to a higher placebo event rate in the ACE inhibitor trials for the outcome of all-cause mortality, cardiovascular death, and myocardial infarction.
https://immattersacp.org/weekly/archives/2016/01/12/6.htm
12 Jan 2016
Trial of apixaban with single and combination antiplatelet therapy in ACS stopped early due to observed increase in major bleeding events
Full-dose anticoagulation, in combination with antiplatelet therapy of any kind in patients with acute coronary syndrome, results in substantial bleeding without any clear additional benefit and should only be considered when required for another condition.
https://immattersacp.org/weekly/archives/2015/08/11/4.htm
11 Aug 2015
Angina not associated with mortality in diabetes patients with coronary artery disease
Patients with type 2 diabetes and stable coronary artery disease had similar risk of cardiovascular events and death, regardless of whether they had angina or angina-like symptoms, a study found.
https://immattersacp.org/weekly/archives/2013/02/12/2.htm
12 Feb 2013
MKSAP Quiz: Evaluation of risk for cardiovascular disease
A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/02/09/3.htm
9 Feb 2016
No link seen between calcium intake with or without vitamin D and CVD in healthy adults
Obtaining calcium from food rather than supplements is preferred, but supplements can be used safely in patients whose calcium intake is not sufficient, the report said.
https://immattersacp.org/weekly/archives/2016/10/25/1.htm
25 Oct 2016
Joplin hospital rebuilds, better than before
After a tornado in 2011 destroyed St. John's Medical Center in Joplin, Mo., a new facility will open that will focus on a patient-centered experience, from the aesthetics to the wayfinding to storage and security.
https://immattersacp.org/archives/2014/10/joplin.htm
1 Oct 2014